![Calveley Peter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Calveley Peter is currently the Chief Operating Officer at Westlake Biopartners LLC since 2021.
Prior to this, he worked as a Managing Director at Leerink Partners LLC from 2010 to 2019.
Mr. Peter completed his undergraduate degree from Queen's University in 2001 and received an MBA from UCLA Anderson School of Management in 2007.
Aktiva positioner av Calveley Peter
| Företag | Position | Start |
|---|---|---|
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Verksamhetschef | 2021-02-01 |
Tidigare kända positioner av Calveley Peter
| Företag | Position | Slut |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Direktör/Styrelseledamot | 2019-09-30 |
Calveley Peters utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
99
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westlake Biopartners LLC
Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Finance |
